To investigate whether upregulation of Kpnβ1 could alter the response of cancer cells to cisplatin treatment, cisplatin IC50 values were compared in HeLa EGFP and Kpnβ1-EGFP cells. This evidence concerns the gene KPNB1 and cancer.